MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$52,599K
EPS
-$1.34
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
32,672
General and administrative
23,713
Total operating expenses
56,385
Net operating loss
-56,385
Interest income
3,819
Interest expense
0
Other (expense) income, net
-33
Net loss
-52,599
Basic EPS
-1.34
Diluted EPS
-1.34
Basic Average Shares
39,217,244
Diluted Average Shares
39,217,244
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$52,599K Interest income$3,819K Net operating loss-$56,385K Other (expense)income, net-$33K Total operatingexpenses$56,385K Research and development$32,672K General andadministrative$23,713K

TENAX THERAPEUTICS, INC. (TENX)

TENAX THERAPEUTICS, INC. (TENX)